Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SRD5A1 |
| Upstream (Parents) |
|---|
| (<<) PEMT → SRD5A1 |
| (<<) SORD → SRD5A1 |
| (<<) GPT → SRD5A1 |
| (<<) HMGCL → SRD5A1 |
| Downstream (Children) |
|---|
| SRD5A1 → EYA1 (>>) |
| SRD5A1 → FABP7 (>>) |
| SRD5A1 → MAS1 (>>) |
| SRD5A1 → ADCY10 (>>) |
| SRD5A1 → CTLA4 (>>) |
| SRD5A1 → PIK3R3 (>>) |
| SRD5A1 → CYP4F12 (>>) |
| SRD5A1 → SLC22A3 (>>) |
| SRD5A1 → PDZRN3 (>>) |
| SRD5A1 → ALDH7A1 (>>) |
